Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from William Blair

Is Palantir Stock a Buy, Sell, or Hold on New Nuclear Deal?

Palantir stock remains in focus as the big data analytics firm teamed up with The Nuclear Company. William Blair recommends caution in buying PLTR shares.

QuantumScape Just Announced a Major Cobra Milestone. How Should You Play QS Stock Here?

QuantumScape Just Announced a Major Cobra Milestone. How Should You Play QS Stock Here?

QuantumScape stock soars on successful integration of Cobra separator process into baseline cell production. William Blair recommends selling QS shares before they fade again.

Palantir Is Reportedly Building a US ‘Spy Machine.’ How Should You Play PLTR Stock Here?

Palantir Is Reportedly Building a US ‘Spy Machine.’ How Should You Play PLTR Stock Here?

Palantir is reportedly building a “spy machine” for the Trump administration. William Blair remains bearish on PLTR shares for the remainder of 2025.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Legal tech startup ProfitSolv seeks buyer amid sluggish merger climate

Bankers don’t expect “Trump Bump” will boost mergers this year

Palantir Stock Gets Upgrade: Is it Time to Buy PLTR After Recent Slump?

Leading broker William Blair, an erstwhile cynic has recently upgraded the stock.

DeepSeek Upended Wall Street's Rosy View Of AI Stocks Like Nvidia. What That Means For U.S. Hopes To Outrun China.

While AI stocks may rebound from their DeepSeek-induced market sell-off, the U.S. clearly faces a threat from China in artificial intelligence. What you should know.

Investors Business Daily

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says

Axsome's AXS-12 met Phase 3 trial goals, cutting cataplexy attacks by 77% over six months and improving cognition with a favorable safety profile.

inkl

Read news from The Economist, FT, and more,
with one subscription

PTC Therapeutics Ends Utreloxastat Development After Rare Neurodegenerative Disease Trial Misses Goal, Analyst Maintains Outperform With Focus On Sepiapterin, Huntington's Programs

PTC Therapeutics Ends Utreloxastat Development After Rare Neurodegenerative Disease Trial Misses Goal, Analyst Maintains Outperform With Focus On Sepiapterin, Huntington's Programs

PTC Therapeutics halts Utreloxastat development after ALS trial disappoints. Analysts highlight promising pipeline, including Huntington's and PKU programs.

Preserving Wildlife in the Fishing Industry: Expert Angler Will Blair on Conservation Ethics and Sustainable Practices

Preserving Wildlife in the Fishing Industry: Expert Angler Will Blair on Conservation Ethics and Sustainable Practices

The consequences of unsustainable fishing practices are dire. Overfishing not only depletes fish populations but can also alter the entire ecosystem of a region. Will points to Alaska's Alagnak River as a cautionary tale.

International Business Times

1974 brought back to life through powerful Northern Ireland oral history project

1974 brought back to life through powerful Northern Ireland oral history project

The Ulster Museum has unveiled the new project on its website as part of its Troubles And Beyond programme.

The Independent UK

Broadcom, Cava Lead Five Stocks Near Buy Points

Broadcom, Cava Lead Five Stocks Near Buy Points

Artificial intelligence chip stalwart Broadcom and fast-casual pacesetter Cava Group lead this watchlist of five stocks near buy points.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Lanarkshire man who abused young girl and woman is jailed

Lanarkshire man who abused young girl and woman is jailed

Sheriff Alasdair MacFadyen said jail was the only appropriate sentence given the 'gravity' of William Blair's crimes.

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

People

123,835 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

282,553 stories

Northern Ireland

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play